As shown in Figure 4, MET induced apoptosis in prostate cancer cells and, consistently with previous published results [17,84], HO-1 activity inhibition was able to further increase the cytotoxic effect induced by metformin in DU145 cells, indicating a synergistic effect between the two drugs. Here, HMOX1 is linked to prostate carcinoma.